Molecular and Functional Characterization of Monoclonal Antibodies

Therapeutic Monoclonal Antibodies: From Bench to Clinic

Volumn , Issue , 2009, Pages 525-540

  Zhao, Qinjian ^a   Stadheim, Terrance A ^b   Chen, Lorenzo ^a   Washabaugh, Michael W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b GlycoFi Incorporated   (United States)

Author keywords

Glycosylation and glycan analysis enzymatic release of N linked glycans; Molecular and functional characterization of monoclonal antibodies; Molecular heterogeneity

Indexed keywords

EID: 84890970713     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470485408.ch23     Document Type: Chapter

References (41)

1. Anders, J.C., B.F. Parten, G.E. Petrie, R.L. Marlowe, and J.E. McEntire. 2003. Using amino acid analysis to determine absorptivity constants. BioPharm. Int. 16:30-37.
2. Battersby, J.E., B. Snedecor, C. Chen, K.M. Champion, L. Riddle, and M. Vanderlaan. 2001. Affinity-reversed phase liquid chromatography assay to quantitate recombinant antibodies and antibody fragments in fermentation broth. J. Chromatogr. A 927:61-76.
3. Bigge, J.C., T.P. Patel, J.A. Bruce, P.N. Goulding, S.M. Charles, and R.B. Parekh. 1995. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal. Biochem. 230(2):229-238.
4. Cacia, J., R. Keck, L.G. Presta, and J. Frenz. 1996. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: Identification and effect on binding affinity. Biochemistry 35:1897-1903.
5. Chelius, D., et al. 2006. Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. Anal. Chem. 78(7):2370-2376.
6. Chirino, A.J., and Mire-Sluis, A. 2004. Characterizing biological products and assessing comparability following manufacturing changes. Nature Biotechnol. 22:1383-1391.
7. Chumsae, C., et al. 2007. Comparison of methionine oxidation in thermal stability and chemically stressed samples of a fully human monoclonal antibody. J. Chromatogr. B 850(1-2):285-294.
8. Cohen, S.L., C. Price, and J. Vlasak. 2007. Beta-elimination and peptide bond hydrolysis: Two distinct mechanisms of human IgG1 hinge fragmentation upon storage. J. Am. Chem. Soc. 129:6976-6977.
9. Cordoba, A.J., B.J. Shyong, D. Breen, and R.J.J. Harris. 2005. Non-enzymatic hinge region fragmentation of antibodies in solution. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 818:115-121.
10. Goldman, M.H., D.C. James, M. Rendall, A.P. Ison, M. Hoare, and A.T. Bull. 1998. Monitoring recombinant human interferon-gamma N-glycosylation during perfused fluidized-bed and stirred-tank batch culture of CHO cells. Biotechnol. Bioeng. 60(5):596-607.
11. Gorman, J.J., T.P. Wallis, and J.J. Pitt. 2002. Protein disulfide bond determination by mass spectrometry. Mass Spectrometry Rev. 21(3):183-216.
12. Harris, R.J., A.A. Murnane, S.L. Utter, K.L. Wagner, E.T. Cox, G. Polastri, J.C. Helder, and M.B. Sliwkowski. 1993. Assessing genetic heterogeneity in production cell lines: Detection by peptide mapping of a low level Tyr to Gln sequence variant in a recombinant antibody. Biotechnology 11:1293-1297.
13. Harris, R.J., S.J. Shire, and C. Winter. 2004. Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies. Drug Dev. Res. 61:17.
14. Herman, A.C., T.C. Boone, and H.S. Lu. 1996. Characterization, formulation, and stability of Neupogen (filgras-tim), a recombinant human granulocyte colony-stimulating factor. In Formulation, Characterization, and Stability of Protein Drugs, ed. R. Pearlman and Y.J. Wang, 303-328. New York: Plenum Press.
15. High, K., Y. Meng, M. Washabaugh, and Q. Zhao. 2005. Determination of picomolar equilibrium dissociation constants in solution by enzyme-linked immunosorbent assay with fluorescence detection. Anal. Biochem 347:159-161.
16. Jefferis, R. 2001. Glycosylation of human IgG antibodies: Relevance to theraputic applications. BioPharm (International) 14:19-26.
17. Kelly, S.M., and N.C. Price. 2000. The use of circular dichroism in the investigation of protein structure and function. Curr. Protein Pept. Sci. 1:349-384.
18. Li, H., N. Sethuraman, T.A. Stadheim, et al. 2006. Optimization of humanized IgGs in glycoengineered Pichia pastoris. Nature Biotechnol. 24(2):210-215.
19. Lim, A., A. Reed-Bogan, and B.J. Harmon. 2008. Glycosylation profiling of atherapeutic recombinant monoclonal antibody with two N-linked glycosylation sites using liquid chromatography coupled to a hybrid quadrupole time-of-flight mass spectrometer. Anal. Biochem. 375(2):163-172.
20. Liu, H., et al. 2006. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody. Immunol. Lett. 106(2):144-153.
21. Liu, H., D. Faldu, C. Chumsae, and J. Sun. 2008. Heterogeneity of monoclonal antibodies. J. Pharm. Sci. 97(7):2426-2447.
22. Maas, C., et al. 2007. A role for protein misfolding in immunogenicity of biopharmaceuticals. J. Biol. Chem 282(4):2229-2236.
23. Macchi, F.D., F.J. Shen, R.G. Keck, and R.J. Harris. 2001. The continuing role of amino acid analysis in a biotechnology laboratory. In Amino Acid Analysis Protocols, ed. C. Cooper, N. Packer, and K. Williams, 9-30. Methods in Molecular Biology no. 159. Totowa, NJ: Humana Press.
24. Meng, Y., K. High, J. Antonello, M. Washabaugh, and Q. Zhao. 2005. Enhanced sensitivity and precision in an enzyme-linked immunosorbent assay with fluorogenic substrates compared with commonly used chromogenic substrates. Anal. Biochem. 345:227-236.
25. Okazaki, A., E. Shoji-Hosaka, K. Nakamura, et al. 2004. Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. J. Mol. Biol. 336(5): 1239-1249.
26. Pace, C.N., et al. 1995. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4(11):2411-2423.
27. Papac, D.I., J.B. Briggs, E.T. Chin, and A.J. Jones. 1998. A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectro-metric analysis. Glycobiology 8(5):445-454.
28. Rao, P.E., and D.J. Kroon. 1993. Orthoclone OKT3. Chemical mechanisms and functional effects of degradation of a therapeutic antibody. In Stability and Characterization of Protein and Peptide Drugs: Case Histories, ed. Y.J. Wang and R. Pearlman, 135-158. New York: Plenum Press.
29. Riddles, P.W., R.L. Blakely, and B. Zerner. 1979. Ellman's reagent: 5,5'-dithiobis(2-nitrobenzoic acid): A reex-amination. Anal. Biochem. 94:75-81.
30. Rothman, R.J., B. Perussia, D. Herlyn, and L. Warren. 1989. Antibody-dependent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylation. Mol. Immunol. 26(12):1113-1123.
31. Shen, F.J., M.Y. Kwong, R.G. Keck, and R.J. Harris. 1996. The application of tert-butylhydroperoxide oxidation to study sites of potential methionine oxidation in a recombinant antibody. In Techniques in Protein Chemistry, vol. 7, ed. D. Marshak, 275-284. San Diego: Academic Press.
32. Shields, R.L., J. Lai, R. Keck, et al. 2002. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277(30):26733-26740.
33. Srebalus Barnes, C.A., and A. Lim. 2007. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. Mass Spectrometry Rev. 26(3):370-388.
34. Tarentino, A.L., C.M. Gomez, and T.H. Plummer, Jr. 1985. Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase F. Biochemistry 24(17):4665-4671.
35. Tous, G.I., Z. Wei, J. Feng, S. Bilbulian, S. Bowen, J. Smith, R. Strouse, P. McGeehan, J. Casas-Finet, and M.A. Schenerman. 2005. Characterization of a novel modification to monoclonal antibodies: Thioether cross-link of heavy and light chains. Anal. Chem. 77:2675-2682.
36. Wan, M., F.Y. Shiau, W. Gordon, and G. Wang. 1999. Variant antibody identification by peptide mapping. Biotechnol. Bioeng. 62:485-488.
37. Weitzhandler, M., M. Hardy, M.S. Co, and N. Avdalovic. 1994. Analysis of carbohydrates on IgG preparations. J. Pharm. Sci. 83(12):1670-1675.
38. Wenger, M., P. DePhillips, and L. Chen. 2006. Evaluating the Disulfide Map of a Recombinant Membrane Protein by LC/MS/MS. (54th ASMS Conference on Mass Spectrometry and Allied Topics, Seattle, WA.)
39. Wright, A., and S.L. Morrison. 1997. Effect of glycosylation on antibody function: Implications for genetic engineering. Trends Biotechnol. 15(1):26-32.
40. Zhang, W., and M.J. Czupryn. 2002. Free sulfhydryl in recombinant monoclonal antibodies. Biotechnol. Prog. 18:509-513.
41. Zhang, W., L.A. Marzilli, J.C. Rouse, and M.J. Czupryn. 2002. Complete disulfide bond assignment of a recombinant immunoglobulin G4 monoclonal antibody. Anal. Biochem. 311(1):1-9.